<code id='747F655DE7'></code><style id='747F655DE7'></style>
    • <acronym id='747F655DE7'></acronym>
      <center id='747F655DE7'><center id='747F655DE7'><tfoot id='747F655DE7'></tfoot></center><abbr id='747F655DE7'><dir id='747F655DE7'><tfoot id='747F655DE7'></tfoot><noframes id='747F655DE7'>

    • <optgroup id='747F655DE7'><strike id='747F655DE7'><sup id='747F655DE7'></sup></strike><code id='747F655DE7'></code></optgroup>
        1. <b id='747F655DE7'><label id='747F655DE7'><select id='747F655DE7'><dt id='747F655DE7'><span id='747F655DE7'></span></dt></select></label></b><u id='747F655DE7'></u>
          <i id='747F655DE7'><strike id='747F655DE7'><tt id='747F655DE7'><pre id='747F655DE7'></pre></tt></strike></i>

          Home / fashion / knowledge

          knowledge


          knowledge

          author:focus    Page View:559
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In